PACIRA BIOSCIENCES, INC. (PCRX) Shareholders’ equity 2016–2025
PACIRA BIOSCIENCES, INC. (PCRX) shareholders’ equity at each fiscal year-end, per SEC filings.
$693.1MFY2025 · since FY2016: $219.0M → $693.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $693.1M | -11.0% |
| FY2024 | $778.3M | -10.5% |
| FY2023 | $870.1M | +12.3% |
| FY2022 | $775.0M | +6.1% |
| FY2021 | $730.4M | +17.9% |
| FY2020 | $619.7M | +74.6% |
| FY2019 | $354.9M | +10.5% |
| FY2018 | $321.2M | +14.9% |
| FY2017 | $279.5M | +27.6% |
| FY2016 | $219.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice